Delivery Order SPE2DB22D3301-SPE2DB25FZ0RU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,335.16 to AmerisourceBergen Drug Corp for Advair HFA 115-21 microgram inhalers (12 grams) on August 28, 2025, with an ultimate completion date of August 29, 2025. This is a firm fixed price, non-set-aside contract with performance at the vendor's Conshohocken, Pennsylvania location. The delivery order represents a small-value transaction under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,690.54 to AmerisourceBergen Drug Corp for the supply of Advair HFA 115-21 microgram inhalers (8 grams) with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $14,592.35 to AmerisourceBergen Drug Corp for Advair HFA 115-21 microgram inhalers (12 grams) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price, non-set-aside contract represents a routine pharmaceutical supply delivery under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $2,618.19 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $9,483.95 to AmerisourceBergen Drug Corp for the supply of Advair HFA 230-21 mcg inhalers (12 grams). The contract is a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and was awarded on July 25, 2025, with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhalers (12 gm) with a ceiling value of $1,987.83. The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, utilizes firm fixed price terms and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Advair HFA 115-21 micrograms inhaler in 12-gram units, valued at $9,119.12. The award is a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 gram units) with a ceiling value of $1,476.11. This is a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $2,210.11 to AmerisourceBergen Drug Corp for Advair HFA 230-21 microgram inhalers (12-gram units) on August 4, 2025, with completion scheduled for August 5, 2025. This non-set-aside contract utilized firm fixed pricing and was performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order valued at $5,393.88 to Amerisourcebergen Drug Corp, a leading global pharmaceutical distributor, for the provision of Advair HFA 115-21 mcg inhalers. This delivery order, with a period of performance through April 2, 2024, is issued under an indefinite delivery contract (IDC) with a potential value of up to $999,999,999.00 that enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0RUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,600.58 to AmerisourceBergen Drug Corp for Advair HFA 115-21 microgram inhalers (12-gram units). This firm fixed-price, non-set-aside contract was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025. The work will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters. This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical prime vendor agreement running through December 2026. AmerisourceBergen serves as a critical pharmaceutical distributor for federal medical procurement, supplying a broad range of medications, medical devices, and healthcare commodities to support military and veteran healthcare systems. The Advair HFA inhaler delivery supports the Defense Health Agency and other government healthcare customers through this flexible contract vehicle, which enables the company to fulfill recurring pharmaceutical needs across multiple therapeutic domains on a global basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 9/8/25 |